Relationship between metalloproteinase-2 and -9 levels in plasma and vaginal secretion with preterm birth
- 1 June 2021
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 261, 217-221
Abstract
No abstract availableKeywords
Funding Information
- FAPESP
This publication has 34 references indexed in Scilit:
- Matrix Metalloproteinase-1 and -9 in Human Placenta during Spontaneous Vaginal Delivery and Caesarean Sectioning in Preterm PregnancyPLOS ONE, 2012
- Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curvesCurrent Opinion in HIV and AIDS, 2010
- Polymorphisms in the MTHRF, VDR, MMP-9 and IL-β Genes and the Risk of Premature Rupture of MembranesGynecologic and Obstetric Investigation, 2010
- Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal OutcomesAmerican Journal of Perinatology, 2010
- The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidityBulletin of the World Health Organization, 2010
- Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory responseJournal of Perinatal Medicine, 2010
- Minireview: Fetal-Maternal Hormonal Signaling in Pregnancy and LaborMolecular Endocrinology, 2009
- Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessmentUltrasound in Obstetrics & Gynecology, 2008
- The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labourFrontiers in Bioscience-Landmark, 2007
- Changes in the cervical extracellular matrix during pregnancy and parturitionJournal of Perinatal Medicine, 1999